documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
18 rows where docket_id = "FDA-2000-N-0108" and posted_year = 2003 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, comment_end_date, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-N-0108-0008 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab B - "OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 79-174) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:17:41Z | 0 | 0 | 09000064804c2946 | |||
| FDA-2000-N-0108-0012 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab A - "OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 200-307) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:34:12Z | 0 | 0 | 09000064804c2951 | |||
| FDA-2000-N-0108-0018 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab A - "OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 308-406) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:36:23Z | 0 | 0 | 09000064804c2967 | |||
| FDA-2000-N-0108-0013 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab B - "OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 377-464) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:27:30Z | 0 | 0 | 09000064804c2954 | |||
| FDA-2000-N-0108-0017 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab B - "OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 278-376) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:21:09Z | 0 | 0 | 09000064804c2964 | |||
| FDA-2000-N-0108-0015 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab B - "OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 1-78) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:11:52Z | 0 | 0 | 09000064804c295e | |||
| FDA-2000-N-0108-0011 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab A - "OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 100-199) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:32:47Z | 0 | 0 | 09000064804c294e | |||
| FDA-2000-N-0108-0009 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Reference Regulations Policy Management Staff to the Docket, OMB Review March 14, 2003, Executive Order 12866" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2016-02-24T16:51:58Z | 0 | 0 | 09000064804c294a | |||
| FDA-2000-N-0108-0016 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab B - "OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 175-277) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:19:39Z | 0 | 0 | 09000064804c2961 | |||
| FDA-2000-N-0108-0014 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab A - "OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 407-464) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:35:14Z | 0 | 0 | 09000064804c2957 | |||
| FDA-2000-N-0108-0010 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Tab A - "OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 1-99) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:16:06Z | 0 | 0 | 09000064804c294b | |||
| FDA-2000-N-0108-0007 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Safety Reporting Requirements for Human Drug and Biological Products; Extension of Comment Period | Proposed Rule | NEC-Notice of Extension | 2003-07-01T04:00:00Z | 2003 | 7 | 2003-06-17T04:00:00Z | 2003-10-15T03:59:59Z | 2016-12-21T02:02:24Z | 0 | 0 | 09000064804c2749 | |
| FDA-2000-N-0108-0001 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Notice of Proposed Rulemaking re Safety Reporting Requirements for Human Drug and Biological Products See FDA-2000-N-0108-0006 | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2003-03-18T05:00:00Z | 2003 | 3 | 2003-03-18T05:00:00Z | 2003-07-15T03:59:59Z | 2016-12-24T19:42:06Z | 0 | 0 | 09000064804c265e | |
| FDA-2000-N-0108-0006 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Notice of Proposed Rulemaking re Safety Reporting Requirements for Human Drug and Biological Products | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2003-03-18T05:00:00Z | 2003 | 3 | 2003-03-18T05:00:00Z | 2003-07-15T03:59:59Z | 2016-02-24T19:29:20Z | 0 | 0 | 09000064804c2702 | |
| FDA-2000-N-0108-0004 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | See FDA-2000-N-0108-0006 | Supporting & Related Material | 2003-03-18T00:00:00Z | 2003 | 3 | 2016-03-02T20:20:20Z | 0 | 1 | 09000064804c26fd | ||||
| FDA-2000-N-0108-0002 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | See FDA-2000-N-0108-0006 | Supporting & Related Material | 2003-03-18T00:00:00Z | 2003 | 3 | 2016-02-24T19:16:56Z | 0 | 1 | 09000064804c26f7 | ||||
| FDA-2000-N-0108-0003 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | See FDA-2000-N-0108-0006 | Proposed Rule | 2003-03-18T00:00:00Z | 2003 | 3 | 2016-03-02T20:23:54Z | 0 | 1 | 09000064804c26fb | ||||
| FDA-2000-N-0108-0005 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | See FDA-2000-N-0108-0006 | Supporting & Related Material | 2003-03-18T00:00:00Z | 2003 | 3 | 2016-03-02T19:41:42Z | 0 | 1 | 09000064804c2700 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);